Prevention of phosphatidylinositol 3'-kinase-Akt survival signaling pathway during topotecan-induced apoptosis

Cancer Research

Volumn 60, Issue 18, 2000, Pages 5303-5309

  Nakashio, A ^a   Fujita, N ^a   Rokudai, S ^a   Sato, S ^a   Tsuruo, T ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CAMPTOTHECIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN SERINE THREONINE KINASE; TOPOTECAN;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL PROTECTION; CELL SURVIVAL; CONTROLLED STUDY; CYTOTOXICITY; DEPHOSPHORYLATION; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; HUMAN CELL; LUNG CANCER; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANTINEOPLASTIC AGENTS; APOPTOSIS; CASPASES; ENZYME ACTIVATION; ENZYME INHIBITORS; HUMAN; LUNG NEOPLASMS; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; SIGNAL TRANSDUCTION; SUPPORT, NON-U.S. GOV'T; TOPOTECAN; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0034665134     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Mechanism of activation and function of protein kinase B
2. Dimerization of cell surface receptors in signal transduction
3. Requirement for phosphatidylinositol-3 kinase in the prevention of apoptosis by nerve growth factor. Science (Washington DC)
4. Phosphoinositide 3-kinases: A conserved family of signal transducers
5. Signalling through the lipid products of phosphoinositide-3-OH kinase
6. Role of phosphoinositide 3-OH kinase in cell transformation and control of the actin cytoskeleton by Ras
7. PI3K: Downstream AKTion blocks apoptosis
8. A retroviral oncogene, akt, encoding a serine-threonine kinase containing an SH2-like region
9. PDK1 acquires PDK2 activity in the presence of a synthetic peptide derived from the carboxyl terminus of PRK2
10. Characterization of a 3-phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase Bα
11. Protein kinase B kinases that mediate phosphatidylinositol 3,4,5-trisphosphate-dependent activation of protein kinase B
12. Protein kinase C isotypes controlled by phosphoinositide 3-kinase through the protein kinase PDK1
13. Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery
14. Regulation of cell death protease caspase-9 by phosphorylation
15. Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor
16. NF-κB is a target of AKT in anti-apoptotic PDGF signalling
17. Evaluation of 9-dimethylaminomethyl-10-hydroxycamptothecin against xenografts derived from adult and childhood solid tumors
18. β-Lapachone-mediated apoptosis in human promyelocytic leukemia (HL-60) and human prostate cancer cells: A p53-independent response
19. Altered formation of topotecan-stabilized topoisomerase I-DNA adducts in human leukemia cells
20. Factors affecting topotecan sensitivity in human leukemia samples
21. Induction of apoptosis by camptothecin and topotecan
22. Topotecan, a novel topoisomerase I inhibitor: Pharmacology and clinical experience
23. Inhibition of the anti-apoptotic PI(3)K/Akt/Bad pathway by stress
24. Decreased expression of DNA topoisomerase I in camptothecin-resistant tumor cell lines as determined by a monoclonal antibody
25. p21(Wafi/Cip1) acts in synergy with bcl-2 to confer multidrug resistant in a camptothecin-selected human lung cancer cell line
26. Cleavage and inactivation of antiapoptotic Akt/PKB by caspases during apoptosis
27. Type I phosphatidylinositol kinase makes a novel inositol phospholipid, phosphatidylinositol-3-phosphate
28. Cleavage of poly(ADP-ribose) polymerase by a proteinase with properties like ICE
29. The Akt kinase: Molecular determinants of oncogenicity
30. Identification of mammalian DNA topoisomerase I as an intracellular target of the anticancer drug camptothecin
31. The role of cell cycle regulation and apoptosis triggering in determining the sensitivity of leukemic cells to topoisomemse I and II inhibitors
32. Apoptosis induced by anticancer drugs
33. Apoptosis: Its significance in cancer and cancer therapy
34. Resistance to antitumor agent-induced apoptosis in a mutant of human myeloid leukemia U937 cells
35. 2-terminal kinase-mediated activation of interleukin-1β-converting enzyme/CED-3-like protease during anticancer drug-induced apoptosis
36. Activation of actin-cleavable interleukin 1β-converting enzyme (ICE) family protease CPP-32 during chemotherapeutic agent-induced apoptosis in ovarian carcinoma cells
37. Apoptosis as a determinant of tumor sensitivity to topotecan in human ovarian tumors: Preclinical in vitro/in vivo studies
38. Phosphorylation of Ser-241 is essential for the activity of 3-phosphoinositide-dependent protein kinase-I: Identification of five sites of phosphorylation in vivo
39. The phosphoinositide 3-kinase/Akt pathway is activated by daunorubicin in human acute myeloid leukemia cell lines